Karl Simin
Impact in
- Cancer Research top 10%
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Breast Cancer Treatment Studies 6
- Oncology 15
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Anthea LetsouAshraf KhanArthur M. MercurioShaolei LuKavita AroraJoan MassaguéF. Michael HoffmannVern Twombly
- Journals
- Cancer Research (6 papers)Cell Reports (3 papers)Genomics (3 papers)PLoS ONE (3 papers)Breast Cancer Research (2 papers)
- Partner nations
- United StatesSwedenSingapore
In The Last Decade
Karl Simin
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 280
- Oncology 428
- Immunology and Allergy 92
- Molecular Biology 997
- Cell Biology 174
Countries citing papers authored by Karl Simin
This map shows the geographic impact of Karl Simin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Simin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Simin more than expected).
Fields of papers citing papers by Karl Simin
This network shows the impact of papers produced by Karl Simin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Simin. The network helps show where Karl Simin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karl Simin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 25 | |
| 6 | 2022 | 7 | |
| 7 | 2020 | 139 | |
| 8 | 2015 | 187 | |
| 9 | Validation of a multi-marker test that predicts recurrence in patients diagnosed with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery (BCS) | 2015 | 1 |
| 10 | 2012 | 20 | |
| 11 | 2012 | 20 | |
| 12 | 2006 | 17 | |
| 13 | 2005 | 8 | |
| 14 | 2004 | 47 | |
| 15 | 1998 | 41 | |
| 16 | 1995 | 241 | |
| 17 | 1994 | 11 | |
| 18 | 1993 | 9 | |
| 19 | 1993 | 57 | |
| 20 | 1993 | 16 |
About Karl Simin
Karl Simin is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Allergy and Immunology, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cancer-related Molecular Pathways (4 papers), Hedgehog Signaling Pathway Studies (4 papers), Cancer Cells and Metastasis (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Developmental Biology and Gene Regulation (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Cancer Research (280 citations), Oncology (428 citations), Immunology and Allergy (92 citations), Molecular Biology (997 citations) and Cell Biology (174 citations). Karl Simin has collaborated with scholars based in United States, Sweden and Singapore. Frequent co-authors include Anthea Letsou, Ashraf Khan, Arthur M. Mercurio, Shaolei Lu, Kavita Arora, Joan Massagué, F. Michael Hoffmann, Vern Twombly, Michael B. O’Connor and William M Gelbart. Their work appears in journals such as Cancer Research, Cell Reports, Genomics, PLoS ONE and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.